Mario Tiribelli
University of Udine(IT)Ospedale Santa Maria della Misericordia di Udine(IT)Azienda Sanitaria Universitaria Integrata di Trieste(IT)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research
Most-Cited Works
- → Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia(2006)510 cited
- → Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia(2009)210 cited
- → The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR -positive hypereosinophilic syndrome. Results of a multicenter prospective study(2007)192 cited
- → Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)(2006)156 cited
- → Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis(2019)145 cited
- The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.(2006)